| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 09/03/2009 | US20090221478 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases |
| 09/03/2009 | US20090221477 Linkers |
| 09/03/2009 | US20090221476 Peptide Capable of Altering Tubulin Polymerization and use Thereof for Inhibiting Cell Proliferation |
| 09/03/2009 | US20090221474 Histone deacetylases, and uses related thereto |
| 09/03/2009 | US20090221098 Methods and compositions for obtaining and using biologically active multi-protein complexes |
| 09/03/2009 | US20090221097 Method or agent for inhibiting the function of efflux pump of pseudomonas aeruginosa |
| 09/03/2009 | US20090221094 Anthrax Polypeptide Binding |
| 09/03/2009 | US20090221077 Process for producing cytotoxic lymphocytes |
| 09/03/2009 | US20090221067 Cell lines that express hetero oligomeric taste receptors |
| 09/03/2009 | US20090221038 Twin-Arginine Translocation (TAT) Streptomyces Signal Sequences |
| 09/03/2009 | US20090221037 Fusion protein having the enhanced in vivo activity of erythropoietin |
| 09/03/2009 | US20090221032 Entropic bristle domain sequences and their use in recombinant protein production |
| 09/03/2009 | US20090221029 Pfu replication accessory factors and methods of use |
| 09/03/2009 | US20090221028 Novel Recombinant Human Hepatitis C Virus-Like Particle and Method for Producing the Same |
| 09/03/2009 | US20090221002 Methods of quantifying taste of compounds for food or beverages |
| 09/03/2009 | US20090221000 Methods of quantifying taste of compounds for food or beverages |
| 09/03/2009 | US20090220997 Stimulating G Protein-Coupled Receptors |
| 09/03/2009 | US20090220977 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses |
| 09/03/2009 | US20090220967 Systemic Carnitine Deficiency Gene and Uses Thereof |
| 09/03/2009 | US20090220942 Activated split-polypeptides and methods for their production and use |
| 09/03/2009 | US20090220588 Simultaneous Delivery of Receptors and/or Co-Receptors for Growth Factor Stability and Activity |
| 09/03/2009 | US20090220587 Liposomal drug delivery constructs targeted by lipid-conjugated peptide ligands |
| 09/03/2009 | US20090220543 Expression of Proteins in Plants |
| 09/03/2009 | US20090220538 vaccine for staphylococcal infections |
| 09/03/2009 | US20090220537 Vaccine delivery system |
| 09/03/2009 | US20090220536 HIV vaccine immunogens and immunization strategies to elicit broadly-neutralizing anti-HIV-1 antibodies against the membrane proximal domain of HIV GP41 |
| 09/03/2009 | US20090220535 Therapeutic and prophylactic vaccine for the treatment and prevention of papillomavirus infection |
| 09/03/2009 | US20090220533 Novel T-Helper Antigenic Determinant (THD) Peptides |
| 09/03/2009 | US20090220511 human polypeptides named IFN (interferon)- lambda 1, IFN- lambda 2 and IFN- lambda 3 and IFN- lambda R1; antiviral agents |
| 09/03/2009 | US20090220502 B7 FAMILY MEMBER zB7H6 AND RELATED COMPOSITIONS AND METHODS |
| 09/03/2009 | US20090220495 Cancer Related Genes (PRLR) |
| 09/03/2009 | US20090220491 Binding agents which inhibit myostatin |
| 09/03/2009 | US20090220485 Method for isolation of soluble polypeptides |
| 09/03/2009 | US20090220480 Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| 09/03/2009 | US20090220473 Adir related polymorphisms and applications thereof |
| 09/03/2009 | US20090220470 Ubiquitin binding polypeptides |
| 09/03/2009 | US20090220455 Pharmaceutical compositions comprising elp fusion proteins |
| 09/03/2009 | US20090220452 Method Of Producing A Modified (POLY) Peptide |
| 09/03/2009 | US20090220435 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 09/03/2009 | US20090220433 Novel biotinylated compositions |
| 09/03/2009 | DE19521720B4 Insulinanalogonformulierungen Insulin analog formulations |
| 09/03/2009 | CA2717276A1 Selenium containing modifying agents and conjugates |
| 09/03/2009 | CA2717086A1 Mutant gene that regulates oil-and-fat content in seed and method for regulating oil-and-fat content in seed |
| 09/03/2009 | CA2716973A1 Novel sequences of brachyspira, immunogenic compositions, methods for preparation and use thereof |
| 09/03/2009 | CA2716849A1 Methods and kits for detecting congenital stationary night blindness and selecting different coat patterns |
| 09/03/2009 | CA2716650A1 Cosmetic or pharmaceutical compositions comprising metalloproteinase inhibitors |
| 09/03/2009 | CA2716648A1 Optimized adhesin fragments and corresponding nanoparticles |
| 09/03/2009 | CA2716622A1 Glycopeptides and methods of making and using them |
| 09/03/2009 | CA2716615A1 An engineered cxcl12 alpha locked dimer polypeptide |
| 09/03/2009 | CA2716180A1 Plants with increased yield |
| 09/03/2009 | CA2713095A1 Biological materials and uses thereof |
| 09/03/2009 | CA2713089A1 Compositions and methods for the treatment of viral infections |
| 09/03/2009 | CA2711841A1 Engineered bacteriophages as adjuvants for antimicrobial agents and compositions and methods of use thereof |
| 09/02/2009 | EP2096174A1 Ubiquitin binding polypeptides |
| 09/02/2009 | EP2096168A1 Diagnostic agent for mesothelioma, diagnosis kit for mesothelioma, and diagnosis method for mesothelioma |
| 09/02/2009 | EP2096120A2 Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 09/02/2009 | EP2096118A1 Antifungal peptides |
| 09/02/2009 | EP2095829A1 Selenium containing modifying agents and conjugates |
| 09/02/2009 | EP2095822A1 Epitope peptides derived from vascular endothelial growth factor receptor 1 and vaccines containing these peptides |
| 09/02/2009 | EP2095119A2 Protein-protein interaction biosensors and methods of use thereof |
| 09/02/2009 | EP2094863A1 Peptide nucleic acid oligomers comprising universal bases, preparation methods thereof, and kits, devices and methods for the analysis, detection or modulation of nucleic acids using the same |
| 09/02/2009 | EP2094845A1 Artificial binding proteins based on a modified alpha helical region of ubiquitin |
| 09/02/2009 | EP2094832A1 Methods and compositions for reducing amyloid beta levels |
| 09/02/2009 | EP2094732A2 Dr6 antibodies inhibiting the binding of dr6 to app, and uses thereof in treating neurological disorders |
| 09/02/2009 | EP2094727A2 Laminin binding site |
| 09/02/2009 | EP2094725A1 Variants and methods of using transforming growth factor beta-9 |
| 09/02/2009 | EP2094724A1 Protein composition for inducing an immune response in a vertebrate comprising a plurality of protein variants covering the heterogeneity of a single antigen, ama1 |
| 09/02/2009 | EP2094722A1 Use of polypetides against diseases caused by protozoans |
| 09/02/2009 | EP2094309A2 Alpha-lactalbumin composition |
| 09/02/2009 | EP2094298A2 Multivalent pneumococcal polysaccharide-protein conjugate composition |
| 09/02/2009 | EP2094297A2 Immunogenic and therapeutic compositions for streptococcus pyogenes |
| 09/02/2009 | EP2094293A1 Tissue targeted antigenic activation of the immune response to treat cancers |
| 09/02/2009 | EP2094292A2 Nitric oxide-blocked cross-linked tetrameric hemoglobin |
| 09/02/2009 | EP1937705A4 Methylation markers for prognosis and treatment of cancers |
| 09/02/2009 | EP1812032A4 Tissue factor composition and methods |
| 09/02/2009 | EP1753448A4 Compositions comprising various proteorhodopsins and/or bacteriorhodopsins and use thereof |
| 09/02/2009 | EP1689886B1 Molecular marker associated with cmv resistance and use thereof |
| 09/02/2009 | EP1682655B1 Carbohydrate-binding modules |
| 09/02/2009 | EP1620056B1 Tumor cytotoxicity induced by modulators of the cxcr4 receptor |
| 09/02/2009 | EP1613761B1 Methods for producing biological substances in enzyme-deficient mutants of aspergillus niger |
| 09/02/2009 | EP1604029B1 Method for increasing resistance against stress factors in plants |
| 09/02/2009 | EP1601770B1 Streptococcus pyogenes antigens |
| 09/02/2009 | EP1601766B1 Peptides capable of inhibiting dimerisation of c-Jun |
| 09/02/2009 | EP1558278B1 Production of homotrimeric fusion proteins |
| 09/02/2009 | EP1557466B1 Tumor antigen protein and utilization thereof |
| 09/02/2009 | EP1523372B1 Ghrelin-carrier conjugates |
| 09/02/2009 | EP1478233A4 Method for administering glp-1 molecules |
| 09/02/2009 | EP1466925B1 Antibodies against fibroblast growth factor 23 |
| 09/02/2009 | EP1457498B9 Novel peptide having angiotensin convertase inhibitory effect |
| 09/02/2009 | EP1407022B1 Process for the preparation of l-amino acids using strains of the enterobacteriaceae family which contain an enhanced rsea gene |
| 09/02/2009 | EP1373536B9 Lentiviral packaging constructs |
| 09/02/2009 | EP1364027B1 Zinc finger binding domains for nucleotide sequence ann |
| 09/02/2009 | EP1320595B1 Production process of surfactin |
| 09/02/2009 | EP1317479B1 Methods and compositions for diseases associated with amyloidosis |
| 09/02/2009 | EP1262546B1 Novel scavenger receptors |
| 09/02/2009 | EP1148122B1 PROCESS FOR PRODUCING HMG-CoA REDUCTASE INHIBITOR |
| 09/02/2009 | EP0892643B2 Methods for inhibiting an immune response by blocking the gp39/cd40 and ctla4/cd28/b7 pathways and compositions for use therewith |
| 09/02/2009 | CN101522711A Reconstituted surfactants having improved properties |
| 09/02/2009 | CN101522710A CD4 mimic peptides and their uses |
| 09/02/2009 | CN101522709A Pegylated PTH as PTH receptor modulators and uses thereof |